LLY

1,136.75

-1.98%↓

JNJ

240.59

+1.09%↑

ABBV

227.54

+1.25%↑

UNH

408.27

+0.76%↑

MRK

119.2

-1.13%↓

LLY

1,136.75

-1.98%↓

JNJ

240.59

+1.09%↑

ABBV

227.54

+1.25%↑

UNH

408.27

+0.76%↑

MRK

119.2

-1.13%↓

LLY

1,136.75

-1.98%↓

JNJ

240.59

+1.09%↑

ABBV

227.54

+1.25%↑

UNH

408.27

+0.76%↑

MRK

119.2

-1.13%↓

LLY

1,136.75

-1.98%↓

JNJ

240.59

+1.09%↑

ABBV

227.54

+1.25%↑

UNH

408.27

+0.76%↑

MRK

119.2

-1.13%↓

LLY

1,136.75

-1.98%↓

JNJ

240.59

+1.09%↑

ABBV

227.54

+1.25%↑

UNH

408.27

+0.76%↑

MRK

119.2

-1.13%↓

Search

Halozyme Therapeutics Inc

Fechado

SetorSaúde

69.43 -1.35

Visão Geral

Variação de preço das ações

24h

Atual

Mín

69.16

Máximo

70.8

Indicadores-chave

By Trading Economics

Rendimento

292M

150M

Vendas

-75M

377M

P/E

Médio do Setor

24.818

49.052

EPS

1.221

Margem de lucro

39.832

Funcionários

423

EBITDA

-63M

218M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+21.31% upside

Dividendos

By Acuity

Próximos Ganhos

4 de ago. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

740M

8.4B

Abertura anterior

70.78

Fecho anterior

69.43

Sentimento de Notícias

By Acuity

25%

75%

63 / 344 Ranking em Healthcare

Halozyme Therapeutics Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

12 de jun. de 2026, 23:06 UTC

Social Media
News
ETF Constituents

Invesco QQQ Trust Series I gains after-market, supported by a strong Nasdaq close and SpaceX's debut, maintaining stability since Friday's close.

12 de jun. de 2026, 20:07 UTC

News
Correlated Moves

The USD/DKK is trading higher, reflecting a modest increase since Thursday's close. The US Dollar Index also shows a slight uptick.

12 de jun. de 2026, 20:07 UTC

News

The USD/CZK is trading lower today, reflecting a slight decline since Thursday's close. Recent U.S. producer price data has not significantly impacted the currency pair.

12 de jun. de 2026, 20:07 UTC

News

Baker Hughes oil rig count rises to 433, influencing energy market sentiment. USD/PLN is trading roughly flat during Friday's session.

12 de jun. de 2026, 20:07 UTC

Correlated Moves
Macro Event
News

The U.S. Baker Hughes oil rig count increased to 433, while the Michigan Consumer Sentiment Index rose to a preliminary reading of 48.9. USD/SGD is trading roughly flat.

12 de jun. de 2026, 20:07 UTC

News

The U.S. Baker Hughes oil rig count rose to 433, while USD/THB trades roughly flat since Thursday's close amid routine market fluctuations.

12 de jun. de 2026, 20:07 UTC

News
Macro Event

The USD/SEK exchange rate is lower today, despite a rise in U.S. consumer sentiment reported at 48.9, above expectations.

12 de jun. de 2026, 20:07 UTC

News
Macro Event

USD/HUF trades lower despite a stronger-than-expected Michigan Consumer Sentiment Index, reflecting ongoing inflation concerns and unusual volatility during the session.

12 de jun. de 2026, 20:07 UTC

News

The USD/ZAR is higher, supported by an increase in the Baker Hughes oil rig count, reflecting dynamics in the energy sector impacting currency valuations.

12 de jun. de 2026, 20:02 UTC

News

ASML Holding NV is lower today, even as analysts note strengthening competitive advantages amid diminishing concerns over rival xLight and ongoing demand for its technology.

12 de jun. de 2026, 20:02 UTC

News

Amazon.com Inc. shares are declining amid broadline retail sector weakness, despite recognition of Amazon Web Services as a growth driver.

12 de jun. de 2026, 20:02 UTC

Macro Event
ETF Constituents
News
Macro News
Correlated Moves
Social Media

Financial Select Sector SPDR Fund is higher today, supported by gains in the financial sector and optimism over geopolitical stability following President Trump's Iran negotiations.

12 de jun. de 2026, 20:02 UTC

News
Social Media

Intel's stock rises as Bank of America upgrades to Buy and Google orders three million processing units, reflecting strong market sentiment and bullish options flow.

12 de jun. de 2026, 20:02 UTC

News

Cintas Corp shares are lower as the FTC issues a second request regarding its acquisition of UniFirst, signaling potential delays in the transaction.

12 de jun. de 2026, 20:02 UTC

News

Adobe Inc. shares are trading lower amid analyst downgrades and CFO Dan Durn's upcoming departure. Concerns over a freemium model pressure near-term revenue outlook.

12 de jun. de 2026, 20:01 UTC

News

Speculation about a merger involving Deutsche Telekom has boosted T-Mobile US shares. The stock has shown steady gains since Thursday's close, trading above its 20-day moving average.

12 de jun. de 2026, 19:56 UTC

News
Correlated Moves
Macro Event

Broadcom Inc shares declined as broader market dynamics and economic data weighed on sentiment, despite record Q2 revenue and AI growth.

12 de jun. de 2026, 19:52 UTC

News
Social Media

Workday Inc shares are lower today amid broader declines in the Application Software sector and an insider selling 107,500 shares at $135.54 to $140.37.

12 de jun. de 2026, 19:52 UTC

News
Correlated Moves
Social Media

Wells Fargo raised Qualcomm's price target to $230, contributing to positive sentiment. The stock is trading higher amid optimism for upcoming Investor Day.

12 de jun. de 2026, 19:52 UTC

News

Intuit Inc. shares are lower amid an investigation for securities fraud by Bleichmar Fonti & Auld LLP related to pricing issues for DIY tax filers.

12 de jun. de 2026, 19:51 UTC

News

Amgen Inc. is reassessing data on Tavneos amid FDA scrutiny. Shares are higher as the company challenges the proposal to withdraw the drug's approval.

12 de jun. de 2026, 19:51 UTC

News
ETF Constituents

Health Care Select Sector SPDR Fund declines as key holdings falter, underperforming against gains in Energy, Materials, and Financials sectors.

12 de jun. de 2026, 19:46 UTC

News
Social Media

Alphabet appeals a German court ruling on AI claims and announced a $50 million investment in workforce training, while shares are higher today.

12 de jun. de 2026, 19:42 UTC

News
Social Media

Meta Platforms shares are lower amid reports of widespread service outages affecting Instagram, Facebook, and WhatsApp, with over 62,000 complaints noted.

12 de jun. de 2026, 19:41 UTC

News

Analysts have raised earnings estimates for NetEase, reflecting positive sentiment. Shares are trading higher today, maintaining upward momentum since Thursday's close.

12 de jun. de 2026, 19:41 UTC

News
Correlated Moves
Social Media

Advanced Micro Devices shares rose after Citi upgraded its rating to Buy and raised the price target to $575, citing strong GPU market potential.

12 de jun. de 2026, 19:41 UTC

News
Correlated Moves

Applied Materials Inc is rising amid a broader market rally and Cantor Fitzgerald's price target increase to $650 from $575, reflecting strong investor interest.

12 de jun. de 2026, 19:41 UTC

Social Media
News

WDC shares gain as JPMorgan raises price target to $650.

12 de jun. de 2026, 19:41 UTC

Social Media
News
Correlated Moves
Macro Event

Lam Research Corp shares rise amid a market rally following President Trump's strike cancellation on Iran. Cantor Fitzgerald raised its price target to $425.

12 de jun. de 2026, 19:41 UTC

News

Comcast Corp shares are higher today, driven by gains in the Cable & Satellite sector. The stock remains above Thursday's close despite a slight pullback.

Comparação entre Pares

Variação de preço

Halozyme Therapeutics Inc Previsão

Preço-alvo

By TipRanks

21.31% parte superior

Previsão para 12 meses

Média 85.8 USD  21.31%

Máximo 96 USD

Mínimo 70 USD

Com base em 5 analistas de Wall Street que oferecem metas de preço de 12 meses para Halozyme Therapeutics Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

5 ratings

3

Comprar

2

Manter

0

Vender

Sentimento

By Acuity

63 / 344 Ranking em Saúde

Sentimento de Notícias

Evidência Muito Forte de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Halozyme Therapeutics Inc

Halozyme Therapeutics, Inc., a biopharma technology platform company, researches, develops, and commercializes proprietary enzymes and devices in the United States, Switzerland, Belgium, Japan, and internationally. The company's products are based on the patented recombinant human hyaluronidase enzyme (rHuPH20) that enables delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules and fluids. It offers Hylenex recombinant, a formulation of rHuPH20 to facilitate subcutaneous (SC) fluid administration for achieving hydration to enhance the dispersion and absorption of other injected drugs in SC urography and to enhance resorption of radiopaque agents; rilpivirine, cabotegravir, and N6LS BNAB for the treatment of HIV; ocrelizumab for multiple sclerosis; XYOSTED, an injection for SC administration of testosterone replacement therapy; and ATRS-1902, a proprietary drug device combination product. The company also provides Herceptin (trastuzumab), Herceptin Hylecta, and Phesgo to treat breast cancer; Mabthera SC for the treatment of chronic lymphocytic leukemia; HYQVIA to treat primary immunodeficiency disorders; and DARZALEX for patients with amyloidosis, smoldering myeloma, and multiple myeloma. In addition, it offers Epinephrine Injection to treat allergic reactions; nivolumab+relatlimab and ANTI-TIM3 for the treatment of solid tumors; ARGX-117 for multifocal motor neuropathy; atezolizumab; nivolumab; afgartigimod; teriparatide injections; and OTREXUP, a SC methotrexate injection for adults with severe active rheumatoid arthritis and severe recalcitrant psoriasis, as well as children with active polyarticular juvenile idiopathic arthritis. Further, the company provides ATRS-1902 for adrenal crisis rescue; ARGX-113; and ARGX-117 to treat severe autoimmune diseases in multifocal motor neuropathy. Halozyme Therapeutics, Inc. was founded in 1998 and is headquartered in San Diego, California.
help-icon Live chat